HIBT Lab! Immunai: Noam Solomon

HIBT Lab! Immunai: Noam Solomon

Up next

Vital Farms: Matt O’Hayer. How a serial entrepreneur re-branded the egg

For decades, a dozen eggs was just… a dozen eggs.No story. No real branding. No reason to care who produced them.Then Matt O’Hayer came along and asked a question almost nobody in America was asking: what if store-bought eggs could be different? What if they tasted better, looked ...  Show more

Advice Line: What’s Your Value?

In today’s special episode, Guy and four former show guests talk with callers about how they can prove the value of their products—and themselves.First, Meagan from Vermont questions whether an experiential pop-up concept for her reusable gift wrap and bags is worth the effort. T ...  Show more

Recommended Episodes

Immunai CTO and Co-Founder Luis Voloch on Using Deep Learning to Develop New Drugs - Ep. 176
NVIDIA AI Podcast

What if we could map our immune system to create drugs that can help our bodies win the fight against cancer and other diseases? That’s the big idea behind immunotherapy. The problem: the immune system is incredibly complex. Enter Immunai, a biotechnology company that’s using AI ...  Show more

Battling Pathogens and Building Immunity Begins In Your Gut – Dr. Robynne Chutkan : 998
The Human Upgrade: Biohacking for Longevity & Performance

IN THIS EPISODE OF THE HUMAN UPGRADE™… Robynne Chutkan, M.D., joins the show to talk about a topic that’s foundational to biohacking—resilience. More specifically, resilience that starts in the gut. You’ll learn:

<ul><li>how your microbiome continually ...  Show more

Antibiotics: How to fix a broken market
Business Daily

Antibiotics stopped providing big gains for pharmaceutical companies decades ago, but as bacteria become more resistant to drugs, the world needs new classes of antibiotics to be discovered if we want to prevent the next global health crisis.Dr Tina Joshi, Associate Professor of ...  Show more

Lifting the burden of malaria
Business Daily

A new vaccine could help eliminate the disease. What would that mean for African economies?Manuela Saragosa speaks to the man who led the team behind the new vaccine, which has demonstrated a startling 77% effectiveness in recent drug trials. Adrian Hill of Oxford University's Je ...  Show more